{
"info": {
"nct_id": "NCT02673060",
"official_title": "A Phase 1 Multicenter, Open-label, Dose-escalation Trial of MBC-11, an Etidronate-ara-C Conjugate in Patients With Malignant Tumors With Cancer-induced Bone Disease (CIBD)",
"inclusion_criteria": "* Histologically confirmed malignant tumor (breast cancer, prostate cancer etc)\n* Bone metastases, documented by radiographs, bone scan\n* No available standard chemotherapy or no indication for chemotherapy at the time of screening\n* Eastern Cooperative Oncology Group [ECOG] status 0-2\n* Adequate bone marrow function (hemoglobin ≥ 9 g/dL with or without transfusion requirement, absolute neutrophil count ≥ 1500/mm3, and platelets ≥ 75,000/mm3)\n* Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN], Alanine aminotransferase [ALT] ≤ 2.5 x ULN).\n* Adequate renal function (creatinine ≤ 1.5 x ULN) and creatinine clearance ≥ 50 mL/min [measured or calculated by nomogram]).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Systemic chemotherapy and/or investigational therapy within the previous 4 weeks\n* Fracture ≤ 6 month prior the inclusion in the study\n* Brain metastasis\n* Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed malignant tumor (breast cancer, prostate cancer etc)",
"criterions": [
{
"exact_snippets": "Histologically confirmed malignant tumor",
"criterion": "malignant tumor",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Bone metastases, documented by radiographs, bone scan",
"criterions": [
{
"exact_snippets": "Bone metastases, documented by radiographs, bone scan",
"criterion": "bone metastases",
"requirements": [
{
"requirement_type": "documentation",
"expected_value": [
"radiographs",
"bone scan"
]
}
]
}
]
},
{
"line": "* No available standard chemotherapy or no indication for chemotherapy at the time of screening",
"criterions": [
{
"exact_snippets": "No available standard chemotherapy",
"criterion": "standard chemotherapy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
},
{
"exact_snippets": "no indication for chemotherapy at the time of screening",
"criterion": "indication for chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group [ECOG] status 0-2",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group [ECOG] status 0-2",
"criterion": "ECOG status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Adequate bone marrow function (hemoglobin ≥ 9 g/dL with or without transfusion requirement, absolute neutrophil count ≥ 1500/mm3, and platelets ≥ 75,000/mm3)",
"criterions": [
{
"exact_snippets": "Adequate bone marrow function (hemoglobin ≥ 9 g/dL ...",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 9,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... with or without transfusion requirement",
"criterion": "transfusion requirement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... absolute neutrophil count ≥ 1500/mm3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "mm3"
}
}
]
},
{
"exact_snippets": "Adequate bone marrow function ... platelets ≥ 75,000/mm3",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 75000,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN], Alanine aminotransferase [ALT] ≤ 2.5 x ULN).",
"criterions": [
{
"exact_snippets": "Adequate liver function (bilirubin ≤ 2 x Upper Limit of Normal [ULN]",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "Alanine aminotransferase [ALT] ≤ 2.5 x ULN",
"criterion": "Alanine aminotransferase (ALT) level",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Adequate renal function (creatinine ≤ 1.5 x ULN) and creatinine clearance ≥ 50 mL/min [measured or calculated by nomogram]).",
"criterions": [
{
"exact_snippets": "Adequate renal function (creatinine ≤ 1.5 x ULN)",
"criterion": "creatinine",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "creatinine clearance ≥ 50 mL/min",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Systemic chemotherapy and/or investigational therapy within the previous 4 weeks",
"criterions": [
{
"exact_snippets": "Systemic chemotherapy ... within the previous 4 weeks",
"criterion": "systemic chemotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "investigational therapy within the previous 4 weeks",
"criterion": "investigational therapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Fracture ≤ 6 month prior the inclusion in the study",
"criterions": [
{
"exact_snippets": "Fracture ≤ 6 month prior the inclusion",
"criterion": "fracture",
"requirements": [
{
"requirement_type": "time since occurrence",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Brain metastasis",
"criterions": [
{
"exact_snippets": "Brain metastasis",
"criterion": "brain metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"criterions": [
{
"exact_snippets": "Serum calcium levels < 8.5 mg/dL (< 2.2 mmol/L)",
"criterion": "serum calcium levels",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 8.5,
"unit": "mg/dL"
},
{
"operator": "<",
"value": 2.2,
"unit": "mmol/L"
}
]
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}